Biotest and ADMA Biologics agree to deal for immune globulin

01/14/2013 | HealthcareGlobal.com

Biotest Pharmaceuticals has entered a 10-year deal to act as the exclusive global supplier to ADMA Biologics for respiratory syncytial virus immune globulin made from human plasma. As part of the agreement, ADMA secured the right to use Biotest's proprietary fractionation and purification technology for the production of intravenous immune globulin.

View Full Article in:

HealthcareGlobal.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC